X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (34864) 34864
Book Review (7450) 7450
Newsletter (4260) 4260
Publication (2682) 2682
Newspaper Article (453) 453
Book Chapter (338) 338
Conference Proceeding (167) 167
Magazine Article (100) 100
Book / eBook (62) 62
Dissertation (53) 53
Trade Publication Article (37) 37
Web Resource (34) 34
Reference (18) 18
Government Document (14) 14
Paper (7) 7
Streaming Video (5) 5
Data Set (3) 3
Transcript (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (25773) 25773
humans (25498) 25498
chronic myeloid leukemia (12963) 12963
hematology (12098) 12098
oncology (11551) 11551
male (10091) 10091
female (9596) 9596
chronic myeloid-leukemia (9388) 9388
cancer (8736) 8736
chronic myelogenous leukemia (8688) 8688
middle aged (7931) 7931
adult (7833) 7833
research (6646) 6646
leukemia (6548) 6548
aged (5486) 5486
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (5262) 5262
care and treatment (4980) 4980
imatinib mesylate (4977) 4977
leukemia, myelogenous, chronic, bcr-abl positive - genetics (4551) 4551
animals (4550) 4550
imatinib (3871) 3871
antineoplastic agents - therapeutic use (3707) 3707
leukemia, myelogenous, chronic, bcr-abl positive - pathology (3626) 3626
oncology, experimental (3427) 3427
benzamides (3366) 3366
chronic lymphocytic-leukemia (3317) 3317
adolescent (3131) 3131
bcr-abl (3074) 3074
acute myeloid-leukemia (2985) 2985
genetic aspects (2924) 2924
treatment outcome (2904) 2904
pyrimidines - therapeutic use (2839) 2839
transplantation (2832) 2832
apoptosis (2805) 2805
acute lymphoblastic-leukemia (2788) 2788
prognosis (2679) 2679
fusion proteins, bcr-abl - genetics (2643) 2643
analysis (2620) 2620
hemic and lymphatic diseases (2613) 2613
abridged index medicus (2501) 2501
mutation (2451) 2451
piperazines - therapeutic use (2425) 2425
mice (2356) 2356
therapy (2315) 2315
stem cells (2293) 2293
cml (2284) 2284
health aspects (2248) 2248
immunology (2230) 2230
leukemia, myelogenous, chronic, bcr-abl positive - therapy (2131) 2131
antineoplastic agents (2116) 2116
cell biology (2054) 2054
aged, 80 and over (2052) 2052
protein kinase inhibitors - therapeutic use (1999) 1999
antimitotic agents (1983) 1983
drug therapy (1979) 1979
child (1937) 1937
pharmacology & pharmacy (1857) 1857
antineoplastic agents - pharmacology (1852) 1852
risk factors (1849) 1849
expression (1834) 1834
reports (1798) 1798
dasatinib (1733) 1733
biochemistry & molecular biology (1713) 1713
chemotherapy (1682) 1682
tyrosine (1681) 1681
young adult (1609) 1609
philadelphia-chromosome (1585) 1585
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (1566) 1566
bone marrow (1563) 1563
hematology, oncology and palliative medicine (1563) 1563
cells (1560) 1560
transplantation, homologous (1559) 1559
cell line, tumor (1537) 1537
philadelphia chromosome (1531) 1531
gene expression (1507) 1507
medicine & public health (1499) 1499
bone-marrow-transplantation (1498) 1498
diagnosis (1444) 1444
pyrimidines - pharmacology (1432) 1432
proteins (1431) 1431
medicine, research & experimental (1430) 1430
hematopoietic stem cells (1428) 1428
article (1401) 1401
tyrosine kinase (1378) 1378
genetics & heredity (1370) 1370
survival (1365) 1365
tyrosine kinase inhibitors (1335) 1335
tyrosine kinase inhibitor (1333) 1333
retrospective studies (1330) 1330
bone marrow transplantation (1312) 1312
protein-tyrosine kinases - antagonists & inhibitors (1309) 1309
chronic disease (1297) 1297
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (1284) 1284
apoptosis - drug effects (1279) 1279
kinases (1245) 1245
signal transduction (1230) 1230
resistance (1225) 1225
k562 cells (1223) 1223
chronic myelomonocytic leukemia (1219) 1219
development and progression (1217) 1217
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (40) 40
Online Resources - Online (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Credit Valley Hospital - Stacks (2) 2
Scarborough Hospital - General (2) 2
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Media Commons - Audio Visual (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Reference (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37891) 37891
Chinese (414) 414
Japanese (288) 288
French (282) 282
Russian (269) 269
Spanish (269) 269
German (258) 258
Polish (117) 117
Portuguese (82) 82
Czech (61) 61
Hungarian (45) 45
Italian (42) 42
Korean (40) 40
Turkish (38) 38
Dutch (13) 13
Slovenian (11) 11
Danish (9) 9
Slovak (9) 9
Croatian (8) 8
Ukrainian (7) 7
Serbian (6) 6
Swedish (6) 6
Hebrew (5) 5
Norwegian (4) 4
Persian (4) 4
Romanian (4) 4
Finnish (3) 3
Bulgarian (2) 2
Arabic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2016, Methods in molecular biology, ISBN 1493940090, Volume 1465
This volume highlights the molecular and cellular methods used in studying Chronic Myeloid Leukimia (CML) pathogenesis and stem cell biology. Written in the... 
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Chronic myeloid leukemia
Web Resource
2016, Methods in molecular biology, ISBN 1493940090, Volume 1465
This volume highlights the molecular and cellular methods used in studying Chronic Myeloid Leukimia (CML) pathogenesis and stem cell biology. Written in the... 
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Web Resource
2016, ISBN 3319331973
Web Resource
2006, Methods in molecular medicine, ISBN 9781597450171, Volume 125
Web Resource
The New England Journal of Medicine, ISSN 0028-4793, 06/2010, Volume 362, Issue 24, pp. 2251 - 2259
The treatment of chronic myeloid leukemia (CML) achieved a great leap forward with the development of imatinib, a BCR-ABL kinase inhibitor. Alterations in the... 
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, GENERAL & INTERNAL | PHASE CML-CP | MOLECULAR RESPONSES | UP SUSTAINED SURVIVAL | 800 MG | HARMONIZING CURRENT METHODOLOGY | FOLLOW-UP | PATIENTS RECEIVING IMATINIB | PATIENTS PTS | BCR-ABL TRANSCRIPTS | Humans | Leukemia, Myeloid, Chronic-Phase - pathology | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Blast Crisis - prevention & control | Protein Kinase Inhibitors - adverse effects | Young Adult | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Pyrimidines - administration & dosage | Leukemia, Myeloid, Chronic-Phase - drug therapy | Kaplan-Meier Estimate | Piperazines - therapeutic use | Imatinib Mesylate | Piperazines - adverse effects | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Adolescent | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - adverse effects | Aged | Benzamides | Nilotinib | Antiviral agents | Safety and security measures | Chronic myeloid leukemia | Drug therapy | Comparative analysis | Clinical trials | Drug dosages | Medical treatment | Index Medicus | Abridged Index Medicus | bcr-abl | pathology | Leukemia | Chronic-Phase | Myeloid | Klinisk medicin | 80 and over | Pyrimidines | administration & dosage | Fusion Proteins | Blast Crisis | drug therapy | Piperazines | Antineoplastic Agents | prevention & control | antagonists & inhibitors | Clinical Medicine | Protein Kinase Inhibitors | adverse effects | therapeutic use
Journal Article
Nature Genetics, ISSN 1061-4036, 01/2013, Volume 45, Issue 1, pp. 18 - 24
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2010, Volume 363, Issue 26, pp. 2511 - 2521
In this study, adding pegylated interferon alfa-2a to imatinib therapy for chronic myeloid leukemia resulted in a greater reduction in the number of cells... 
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, GENERAL & INTERNAL | CHRONIC GRANULOCYTIC-LEUKEMIA | INTERFERON | POSITIVE CELLS | CHRONIC-PHASE | ABL TYROSINE KINASE | HEMATOPOIETIC STEM-CELLS | FOLLOW-UP | PATIENTS RECEIVING IMATINIB | CYTARABINE | Piperazines - administration & dosage | Humans | Leukemia, Myeloid, Chronic-Phase - pathology | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Polyethylene Glycols - adverse effects | Male | Proto-Oncogene Proteins c-abl - analysis | Cytarabine - adverse effects | Recombinant Proteins | RNA, Neoplasm - analysis | Adult | Female | Transcription, Genetic | Neutropenia - chemically induced | Proto-Oncogene Proteins c-abl - genetics | Pyrimidines - administration & dosage | Leukemia, Myeloid, Chronic-Phase - drug therapy | Anemia - chemically induced | Treatment Outcome | Thrombocytopenia - chemically induced | Imatinib Mesylate | Piperazines - adverse effects | Remission Induction | Cytarabine - administration & dosage | Polyethylene Glycols - administration & dosage | Interferon-alpha - administration & dosage | Leukemia, Myeloid, Chronic-Phase - mortality | Fusion Proteins, bcr-abl - genetics | Fusion Proteins, bcr-abl - analysis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - adverse effects | Survival Analysis | Stem Cells - drug effects | Interferon-alpha - adverse effects | Benzamides | Drug therapy | Chronic myeloid leukemia | Medical research | Kinases | Leukemia | Manuscripts | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2010, Volume 362, Issue 24, pp. 2260 - 2270
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 10, pp. 917 - 927
Journal Article